

Dr Antonio Martorell
Dr Antonio Martorell is a dermatologist at the Hospital de Manises in Valencia, Spain, and an Associate Professor of dermatology at the Catholic University of Valencia. He founded and leads a specialised unit focused mainly on the management of patients with psoriasis, hidradenitis suppurativa and related comorbidities.
Dr Martorell received his degree in medicine and surgery from the University of Valencia and specialised in dermatology at Hospital Instituto Valenciano de Oncología, Valencia, an international reference centre in surgery and oncology.
Dr Martorell’s main scientific areas of interest are psoriasis, hidradenitis suppurativa and hair disorders. His recent research has focused on the epigenetic pathways of hidradenitis suppurativa and skin ultrasound, and he is the founder of the DERMUS Task Force. Dr Martorell has authored 217 PubMed articles and has been the invited speaker for 351 lectures covering topics including psoriasis, hidradenitis suppurativa and skin cancer. He is also the Principal Investigator of over 20 clinical assays in phase II, III and IV clinical trials. In addition, Dr Martorell is the founder and coordinator of the Spanish Working Group on Hidradenitis Suppurativa (GTHS), and since 2022, he has led the innovation and research area of the Spanish Academy of Dermatology and Venereology (AEDV). Dr Martorell is also director of the IADERMA course leading a group focused on eHealth oriented to the development of ICT solutions with the aim of improving basic medical procedures during this new technological era. Dr Martorell holds the position of health manager and project coordinator at E-health in SKIANA®.
Prof. Falk Bechara covers the different surgical options for HS, and experienced nurses from his team discuss the importance of wound care
Prof. Thrasyvoulos Tzellos gives an overview of HS treatment options. Dr Barry McGrath and Prof. Gregor Jemec provide their views on the HCP-patient relationship
Prof. Christos Zouboulis and Dr Axel Villani kick-off the webinar series by explaining the fundamentals of the HS disease story and pathophysiology
Accompany Dr William Tillett and Dr Fabian Proft as they explore the approaches and challenges of managing D2T patients with PsA.
Achieving MDA or DAPSA treatment targets improves quality of life for patients with PsA.1–4 Explore the characteristics of patients who report treatment success...
ASDAS and BASDAI are commonly used in clinical practice.1,2 However, discover recent studies demonstrating that a high proportion of real-world patients do not...